Cargando…

Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors

BACKGROUND: Inflammatory bowel disease (IBD) patients are at increased risk for developing extra-intestinal malignancies, mainly due to immunosuppressive medication. The risk of developing head and neck cancer in immunosuppressed transplant patients is increased. The relation between IBD patients an...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Ven, Steffi E M, Derikx, Lauranne A A P, Nagtegaal, Iris D, van Herpen, Carla M, Takes, Robert P, Melchers, Willem J G, Pierik, Marieke, van den Heuvel, Tim, Verhoeven, Rob H A, Hoentjen, Frank, Nissen, L H C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301406/ https://www.ncbi.nlm.nih.gov/pubmed/31559415 http://dx.doi.org/10.1093/ibd/izz210

Ejemplares similares

Better survival of renal cell carcinoma in patients with inflammatory bowel disease
por: Derikx, Lauranne A.A.P., et al.
Publicado: (2015)

Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2023)

Increased Colorectal Neoplasia Risk in Patients with Inflammatory Bowel Disease and Serrated Polyps with Dysplasia
por: de Jong, Michiel E., et al.
Publicado: (2022)

Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
por: De Jong, Michiel E, et al.
Publicado: (2019)

No Increased Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease and Postinflammatory Polyps
por: de Jong, Michiel E, et al.
Publicado: (2020)

Type C Mucosa in Pouch Surveillance: How Real is the Risk?
por: te Groen, Maarten, et al.
Publicado: (2020)

Long-Term Clinical Outcomes After Switching from Remicade(®) to Biosimilar CT-P13 in Inflammatory Bowel Disease
por: Smits, Lisa J. T., et al.
Publicado: (2017)

A207 CLONAL PATTERNS BETWEEN POUCH NEOPLASIA AND PRIOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN EXPLORATORY COHORT STUDY
por: Van Lierop, L, et al.
Publicado: (2023)

Endoscopic and surgical treatment outcomes of colitis-associated advanced colorectal neoplasia: a multicenter cohort study
por: Derks, Monica EW, et al.
Publicado: (2023)

Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis
por: Savelkoul, Edo H J, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections after COVID-19 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: van de Pol, Natasja, et al.
Publicado: (2023)

Hepatosplenic T-cell lymphoma in a 47-year-old Crohn’s disease patient on thiopurine monotherapy
por: van de Meeberg, Maartje M, et al.
Publicado: (2016)

Reduction in Inflammatory Bowel Disease Healthcare During the Coronavirus Disease 2019 Pandemic: A Nationwide Retrospective Cohort Study
por: te Groen, Maarten, et al.
Publicado: (2021)

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study
por: Derikx, Lauranne A A P, et al.
Publicado: (2020)

A comparative analysis of tioguanine versus low‐dose thiopurines combined with allopurinol in inflammatory bowel disease patients
por: Biemans, Vince B. C., et al.
Publicado: (2020)

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020)

Synoptic reporting increases quality of upper gastrointestinal cancer pathology reports
por: Baranov, Nikolaj S., et al.
Publicado: (2019)

Office‐based CO(2) laser surgery for benign and premalignant laryngeal lesions
por: Wellenstein, David J., et al.
Publicado: (2019)

Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes
por: Voskuil, M D, et al.
Publicado: (2020)

Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021)

Comment on: Surveillance pouchoscopy for dysplasia: Cleveland Clinic Ileoanal Pouch Anastomosis Database
por: Derks, M E W, et al.
Publicado: (2021)

Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort
por: Gros, Beatriz, et al.
Publicado: (2023)

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn’s Disease
por: Straatmijer, Tessa, et al.
Publicado: (2023)

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study
por: Thomas, Pepijn W A, et al.
Publicado: (2022)

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)
por: Driessen, Chantal M., et al.
Publicado: (2019)

Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study
por: Bosch, Steven L., et al.
Publicado: (2019)

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival
por: Brouwer, Nelleke P. M., et al.
Publicado: (2019)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
por: Bosch, Sofie, et al.
Publicado: (2022)

Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population
por: van de Ven, Steffi E. M., et al.
Publicado: (2021)

Translation and cross-cultural adaptation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ)()
por: Bernardes, Rejane P., et al.
Publicado: (2020)

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2022)

Incidental findings in the bowel cancer population screening program: other polyps and malignancies – A nationwide study
por: Nagtegaal, Iris D, et al.
Publicado: (2022)

Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease: A Case-controlled Cohort Study
por: Goetgebuer, R L, et al.
Publicado: (2021)

Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels
por: Sleutjes, Jasmijn A. M., et al.
Publicado: (2021)

Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events
por: Asscher, Vera E. R., et al.
Publicado: (2020)

Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry
por: Giraud, Eline L., et al.
Publicado: (2021)

Untreated Celiac Disease in a Patient with Dermatitis Herpetiformis Leading to a Small Bowel Carcinoma
por: Derikx, Monique H.M., et al.
Publicado: (2012)

Evaluation Criteria for Chromosome Instability Detection by FISH to Predict Malignant Progression in Premalignant Glottic Laryngeal Lesions
por: Bergshoeff, Verona E., et al.
Publicado: (2022)

Merkel Cell Carcinoma: New Trends
por: Zwijnenburg, Ellen M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_phjodc3c2p96plb300ct99p1o1